Literature DB >> 22190465

Inappropriate prescribing of proton pump inhibitors in hospitalized patients.

Mark Reid1, Angela Keniston, J Christie Heller, Marshall Miller, Sofia Medvedev, Richard K Albert.   

Abstract

BACKGROUND: Proton pump inhibitors have numerous important side effects, yet they are prescribed for outpatients who do not have recognized indications. Less is known with respect to prescribing for inpatients.
OBJECTIVE: To determine the rate of inappropriate prescribing of protein pump inhibitors and to assess reasons why they are prescribed. DESIGN AND PARTICIPANTS: The study was a retrospective review of administrative data for adult hospital patients discharged from the Medicine service of Denver Health (DH) and from the University HealthSystem Consortium (UHC) between January 1, 2008 and December 31, 2009. MEASUREMENTS: Valid indications for proton pump inhibitors were sought from discharge diagnoses, prescription records, and, in a randomly selected group of patients from DH, from direct review of records.
RESULTS: Inclusion criteria were met by 9875 DH patients and 6,592,100 UHC patients; of patients receiving a proton pump inhibitor, 61% and 73%, respectively, did not have a valid indication. Increased rates of Clostridium difficile infection were found in both groups of patients receiving proton pump inhibitors. Chart reviews found valid indications for proton pump inhibitors in 19% of patients who did not have a valid indication on the basis of the administrative data, and "prophylaxis" was the justification for inappropriate prescribing in 56%.
CONCLUSION: Proton pump inhibitors are frequently inappropriately prescribed to Medicine inpatients who do not have a valid indication and this practice is associated with an increase in C. difficile infection. Interventions are needed to curtail this inappropriate prescribing practice.
Copyright © 2011 Society of Hospital Medicine.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22190465     DOI: 10.1002/jhm.1901

Source DB:  PubMed          Journal:  J Hosp Med        ISSN: 1553-5592            Impact factor:   2.960


  21 in total

1.  Proton pump inhibitors: Are we still prescribing them without valid indications?

Authors:  Farooq Akram; Yufang Huang; Valencia Lim; Paul J Huggan; Reshma A Merchant
Journal:  Australas Med J       Date:  2014-11-30

2.  Effects of proton pump inhibitor use on risk of Clostridium difficile infection: a hospital cohort study.

Authors:  Yoon Hee Park; Jong Mi Seong; Soyeon Cho; Hye Won Han; Jae Youn Kim; Sook Hee An; Hye Sun Gwak
Journal:  J Gastroenterol       Date:  2019-06-11       Impact factor: 7.527

3.  Do hospitalists overuse proton pump inhibitors? Data from a contemporary cohort.

Authors:  Mohammed Albugeaey; Naimah Alfaraj; Jane Garb; Adrianne Seiler; Tara Lagu
Journal:  J Hosp Med       Date:  2014-08-14       Impact factor: 2.960

4.  Azithromycin and COPD Exacerbations in the Presence or Absence of Symptoms or Active Treatment for Gastroesophageal Reflux.

Authors:  Frederick L Ramos; Sarah M Lindberg; Jason S Krahnke; John Connett; Richard K Albert; Gerard J Criner
Journal:  Chronic Obstr Pulm Dis       Date:  2014-09-25

5.  Assessing the Risk of Hospital-Acquired Clostridium Difficile Infection With Proton Pump Inhibitor Use: A Meta-Analysis.

Authors:  Vanessa Arriola; Jessica Tischendorf; Jackson Musuuza; Anna Barker; Jeffrey W Rozelle; Nasia Safdar
Journal:  Infect Control Hosp Epidemiol       Date:  2016-09-28       Impact factor: 3.254

6.  Adherence with regulatory resolutions on prevention of NSAIDS-related gastrointestinal injury in Italy.

Authors:  Sabrina Montagnani; Marco Tuccori; Arianna Testi; Michele Cristofano; Tiberio Corona; Stefano Salvadori; Carmelo Scarpignato; Corrado Blandizzi
Journal:  Int J Clin Pharm       Date:  2016-03-22

7.  Quantifying Candidacy for Deprescribing of Proton Pump Inhibitors among Long-Term Care Residents.

Authors:  Alanna Doell; Ashley Walus; Jaclyn To; Allison Bell
Journal:  Can J Hosp Pharm       Date:  2018-10-31

8.  Prescribing errors among adult patients in a large tertiary care system in Saudi Arabia.

Authors:  Maryam Ali Alharaibi; Abdullah A Alhifany; Yousif A Asiri; Monira M Alwhaibi; Sheraz Ali; Parameaswari P Jaganathan; Tariq M Alhawassi
Journal:  Ann Saudi Med       Date:  2021-06-01       Impact factor: 1.526

9.  Inappropriate Prescription of Proton Pump Inhibitors in a Community Setting.

Authors:  Patrick Viet-Quoc Nguyen; Raja Tamaz
Journal:  Can J Hosp Pharm       Date:  2018-08-28

10.  Reflux Symptoms: Functional and Structural Diseases and the Approach from the GI Specialist.

Authors:  Lars Lundell
Journal:  Dig Dis       Date:  2021-02-09       Impact factor: 2.404

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.